Non-Alcoholic Fatty Liver Disease (NAFLD)

Non-Alcoholic Fatty Liver Disease (NAFLD) is a prevalent liver disorder characterised by excess fat deposition in the liver cells of those with little or no alcohol intake. It is closely related to obesity, insulin resistance, type 2 diabetes, high cholesterol, and metabolic syndrome. NAFLD is a spectrum of liver disease from simple steatosis or fat deposition to a more aggressive type called non-alcoholic steatohepatitis (NASH) that can lead to liver inflammation, fibrosis, cirrhosis, and liver failure if left untreated.

Many individuals with NAFLD have no obvious symptoms in the early stages. However, some people may become tired, have a small stomach upset, or feel full in the upper right abdomen. Routine blood tests or imaging tests like an ultrasound, CT scan, or MRI commonly reveal the issue.

Management is mostly lifestyle changes. A healthy diet, regular exercise, and treatment of underlying illnesses such as diabetes and high cholesterol can help greatly improve liver health. Weight loss.  Early diagnosis and effective care are crucial to avoid disease development and decrease the risk of significant liver-related consequences while improving overall metabolic health and long-term quality of life.